Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Roy

Showing results (71-80 of 690) with videos related to

Pageof 69
Sort By:
Life (Basel, Switzerland)|December 23, 2022
Catheter-Directed Interventions for the Treatment of Lower Extremity Deep Vein ThrombosisKajol J Shah, Trisha L Roy
Journal of Clinical and Experimental Neuropsychology|March 1, 1988
Williams syndrome: a neuropsychological profileG W MacDonald, D L Roy
American Heart Journal|May 1, 1985
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery diseaseL Roy, J Mehta, P Mehta
Cell Cycle (Georgetown, Tex.)|February 16, 2006
TFII-I: connecting mitogenic signals to cell cycle regulationZana P Desgranges, Ananda L Roy
Gene|January 1, 1986
Two human tyrosine tRNA genes contain intronsJ M MacPherson, K L Roy
Journal of Spinal Disorders & Techniques|August 15, 2002
Posture-dependent isometric trunk extension and flexion strength in normal male and female subjectsTony S Keller, Amy L Roy
The American Journal of Cardiology|February 1, 1983
Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalolL Roy, J Mehta, P Mehta
Trends in Genetics : TIG|September 1, 1996
Core promoters and transcriptional controlC D Novina, A L Roy
The Canadian Journal of Cardiology|January 1, 1992
Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery diseaseI Bairati, L Roy, F Meyer
Indian Journal of Biochemistry & Biophysics|February 1, 1994
Initiator element binding protein TFII-I: a tale of two sitesA L Roy, R G Roeder
Pageof 69

Showing results (71-80 of 690) with videos related to

Sort By:
Pageof 69
Life (Basel, Switzerland)|December 23, 2022
Catheter-Directed Interventions for the Treatment of Lower Extremity Deep Vein ThrombosisKajol J Shah, Trisha L Roy
Journal of Clinical and Experimental Neuropsychology|March 1, 1988
Williams syndrome: a neuropsychological profileG W MacDonald, D L Roy
American Heart Journal|May 1, 1985
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery diseaseL Roy, J Mehta, P Mehta
Cell Cycle (Georgetown, Tex.)|February 16, 2006
TFII-I: connecting mitogenic signals to cell cycle regulationZana P Desgranges, Ananda L Roy
Gene|January 1, 1986
Two human tyrosine tRNA genes contain intronsJ M MacPherson, K L Roy
Journal of Spinal Disorders & Techniques|August 15, 2002
Posture-dependent isometric trunk extension and flexion strength in normal male and female subjectsTony S Keller, Amy L Roy
The American Journal of Cardiology|February 1, 1983
Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalolL Roy, J Mehta, P Mehta
Trends in Genetics : TIG|September 1, 1996
Core promoters and transcriptional controlC D Novina, A L Roy
The Canadian Journal of Cardiology|January 1, 1992
Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery diseaseI Bairati, L Roy, F Meyer
Indian Journal of Biochemistry & Biophysics|February 1, 1994
Initiator element binding protein TFII-I: a tale of two sitesA L Roy, R G Roeder
Pageof 69